Date closed: 12/30/2016
On December 30, 2016, Kalytera Therapeutics, Inc. (Kalytera) and Santa Maria Petroleum Inc. (Santa Maria) completed a reverse triangular merger whereby Kalytera merged with a wholly owned subsidiary of Santa Maria (the Transaction). The Transaction constituted a change of business and a reverse takeover transaction of Santa Maria pursuant to the TSX Venture Exchange Policies.
In connection with the Transaction, Santa Maria consolidated its share capital, was continued from Ontario into British Columbia and completed a named change to Kalytera Therapeutics, Inc.
Kalytera, headquartered in Beverly, Massachusetts, is a developer of a next generation of cannabinoid therapeutics.